2018 Annual Meeting | C145 - Severe TBI: From ICU to Rehabilitation

Date Wednesday 04/25/18

Time 01:00 PM - 03:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Susanne Muehlschlegel, MD, MPH, FAAN

Topic(s) Aging, Dementia, and Behavioral Neurology, Neuro Trauma, Critical Care, and Sports Neurology

Learning Objectives Participants should be familiar with the variety of pathophysiologic mechanisms associated with TBI and how to prevent or minimize secondary brain injury with up-to-date acute management recommendations emphasizing relevant guidelines; and be comfortable using clinical information and imaging techniques to aid in prognostication after severe TBI.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Tracks Neurohospitalist

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
01:00 PM - 01:30 PM	Speaker	Severe TBI in the ICU: Management and Prognosis Susanne Muehlschlegel, MD, MPH, FAAN
01:30 PM - 02:00 PM	Speaker	Imaging in Severe TBI Brian Edlow, MD
02:00 PM - 02:30 PM	Speaker	Pharmacological and Rehabilitative Approaches to Neurological Sequelae of TBI David L. Brody, MD, PhD
02:30 PM - 03:00 PM	Q&A	Questions and Answers

Faculty Disclosures
Susanne Muehlschlegel, MD, MPH, FAAN	Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acasti Pharma Inc.. Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti Pharma Inc.. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of an immediate family member of Dr. Muehlschlegel has received research support from NIH. Dr. Muehlschlegel has a non-compensated relationship as a Member of Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities.
Brian Edlow, MD	Dr. Edlow has received research support from NIH.
David L. Brody, MD, PhD	No disclosure on file